Innate immune receptor C5aR1 regulates cancer cell fate and can be targeted to improve radiotherapy in tumours with immunosuppressive microenvironments

Beach C., MacLean D., Majorova D., Melemenidis S., Nambiar D., Kim R., Valbuena G., Guglietta S., Krieg C., Darvish DM., Suwa T., Easton A., Domingo E., Moon EJ., Jiang D., Jiang Y., Koong A., Woodruff T., Graves E., Maughan T., Buczacki S., Stucki M., Le Q-T., Leedham S., Giaccia A., Olcina M.

DOI

10.1101/2023.01.10.521547

Type

Preprint

Publication Date

2023-01-01T00:00:00+00:00

Permalink More information Close